Rigid Needle Shield: The New Standard for Prefilled Syringes
Rubber compound FM30 is a well know compound offered by all big syringe manufacturers these days. It is a low extractable compound with a high gas permeability and is suitable for producing both a needle shield and a tip cap which are sterilized by ethylene oxide. There is a clear trend to move from the traditional soft needle shield towards rigid needle shield due the advantages it offers like avoiding the risk of needle stick injuries. Also with the growth of auto-injectors, rigid needle shields are preferred over soft needle shields. Datwyler's portfolio only existed out of soft needle shields still 2020 but now the rigid needle shield is available both in 1/2" and 5/8". This offers the opportunity to customers, who are already using FM30 for their needle shields, to easily transfer from a soft to a rigid design. In order to support customers with data to facilitate the choice of a needle shield, studies were conducted which show the excellent functional performance of this new product in the prefilled syringe portfolio of Datwyler. The results of these studies will be shared during this session.
Datwyler
-
Country/Region:Belgium
-
On CPHI since:2015
-
Employees:5000+
Other Content from Datwyler (5)
-
Industry Webinar When Size Matters: Evolution of Self-Delivery Solutions for Subcutaneous Administration
The rising prevalence of Biologics and other sensitive therapeutics in clinical practice, associated to the transitional trend from hospital to home administration are rapidly modifying the landscape of subcutaneous (SC) drug delivery. Such route of administration (SC) empowers patients with the ability to self-administer at home, reducing the burden of frequent clinic visits and supporting the growing shift toward decentralized, patient-centric healthcare.
Traditionally, SC injections have been limited to low volumes (typically ≤2 mL) due to concerns over pain, tissue tolerability, and absorption kinetics. However, emerging therapies—particularly monoclonal antibodies, anti-cancer treatments, and long-acting neurologic formulations—often require higher doses that cannot be feasibly delivered subcutaneously within these conventional volume constraints. Consequently, there is a growing demand for innovative solutions supporting self-administration of larger volumes, without compromising safety, therapeutic efficacy and compliance. Sensing such market pressure, Datwyler has already started to extend its range of NeoFlex™ plungers to complete larger containers, supporting the novel on-body injectors, designed for slow, controlled delivery, expanding the feasible range of SC administration volumes.
A collaborative and open approach among the parties involved with the development of the container closure system (CCS) and the device allows the optimization of pre-verified platform solutions, so to accelerate their time to market and, ultimately, availability to the Patients. -
%20(1).png)
Industry Webinar Different Coated Rubber Solutions for Safe Storage of Innovative Drugs
Learn about the different coating technologies for rubber stoppers, their unique features, and their applications in the pharmaceutical industry. Additionally, discover UltraShield™, Datwyler's latest development that meets the highest demands for drug compatibility and cold storage. -
Brochure Sealing solutions for Vials
Sealing solutions for Vials -
Brochure Sealing solutions for Prefilled Syringes
Sealing solutions for Prefilled Syringes -
Brochure Sealing solutions for Cartridges
Sealing Solution for Cartridges